Ozempic ‘microdosing’ is new weight-loss trend

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
Millions of people have used Ozempic and similar drugs to lose weight, but are unhappy with the way their faces change, ...
According to the study, participants taking Zepbound lost an average of 20.2% of their starting weight after 72 weeks, ...